Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Safety Info. No. 267 Focuses on Reye Syndrome Due to Salicylate
July 9, 2001
- Yamanouchi Forms Alliance with Celera Genomics
July 9, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 9, 2001
- JPMA to Propose New Drug Benefit System: Mr Nagayama
July 9, 2001
- Non-member Countries' Interest in ICH to Be Surveyed
July 9, 2001
- Sysmex: POC Test Information System
July 9, 2001
- JMA Proposes New Medical Fee Payment System by Type of Medical Institution
July 9, 2001
- Tanabe to License DDS Technology to aaiPharma in the US
July 9, 2001
- Council Recommends that Profit-making Companies Operate Hospitals
July 9, 2001
- Medrad to Directly Market Image Diagnostic Systems
July 9, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
July 9, 2001
- JEOL: EIA-based Radical Analyzer
July 9, 2001
- BUSINESS NEWS IN BRIEF -3-
July 9, 2001
- CDFS Committee to Draft GL for Package Inserts for Medical Devices
July 9, 2001
- BUSINESS NEWS IN BRIEF -2-
July 9, 2001
- WORLD NEWS IN BRIEF
July 9, 2001
- BUSINESS NEWS IN BRIEF -1-
July 9, 2001
- Pharmacia Enhances R&D Organization in Japan
July 9, 2001
- Shareholders' Meetings Last Longer Due to Increasing Number of Questions
July 9, 2001
- Superiority of Singulaire over Pranlukast Verified: Banyu Symposium
July 9, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…